These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
118 related items for PubMed ID: 38055247
1. Risk Prediction for Atherosclerotic Cardiovascular Disease With and Without Race Stratification. Ghosh AK, Venkatraman S, Nanna MG, Safford MM, Colantonio LD, Brown TM, Pinheiro LC, Peterson ED, Navar AM, Sterling MR, Soroka O, Nahid M, Banerjee S, Goyal P. JAMA Cardiol; 2024 Jan 01; 9(1):55-62. PubMed ID: 38055247 [Abstract] [Full Text] [Related]
7. Tailoring Risk Prediction Models to Local Populations. Zinzuwadia AN, Mineeva O, Li C, Farukhi Z, Giulianini F, Cade B, Chen L, Karlson E, Paynter N, Mora S, Demler O. JAMA Cardiol; 2024 Nov 01; 9(11):1018-1028. PubMed ID: 39292486 [Abstract] [Full Text] [Related]
8. Galantamine for dementia due to Alzheimer's disease and mild cognitive impairment. Lim AWY, Schneider L, Loy C. Cochrane Database Syst Rev; 2024 Nov 05; 11(11):CD001747. PubMed ID: 39498781 [Abstract] [Full Text] [Related]
9. Pharmacological treatments in panic disorder in adults: a network meta-analysis. Guaiana G, Meader N, Barbui C, Davies SJ, Furukawa TA, Imai H, Dias S, Caldwell DM, Koesters M, Tajika A, Bighelli I, Pompoli A, Cipriani A, Dawson S, Robertson L. Cochrane Database Syst Rev; 2023 Nov 28; 11(11):CD012729. PubMed ID: 38014714 [Abstract] [Full Text] [Related]
13. Lamotrigine versus levetiracetam or zonisamide for focal epilepsy and valproate versus levetiracetam for generalised and unclassified epilepsy: two SANAD II non-inferiority RCTs. Marson AG, Burnside G, Appleton R, Smith D, Leach JP, Sills G, Tudur-Smith C, Plumpton CO, Hughes DA, Williamson PR, Baker G, Balabanova S, Taylor C, Brown R, Hindley D, Howell S, Maguire M, Mohanraj R, Smith PE. Health Technol Assess; 2021 Dec 28; 25(75):1-134. PubMed ID: 34931602 [Abstract] [Full Text] [Related]
16. Undernutrition as a risk factor for tuberculosis disease. Franco JV, Bongaerts B, Metzendorf MI, Risso A, Guo Y, Peña Silva L, Boeckmann M, Schlesinger S, Damen JA, Richter B, Baddeley A, Bastard M, Carlqvist A, Garcia-Casal MN, Hemmingsen B, Mavhunga F, Manne-Goehler J, Viney K. Cochrane Database Syst Rev; 2024 Jun 11; 6(6):CD015890. PubMed ID: 38860538 [Abstract] [Full Text] [Related]
17. A multicomponent psychosocial intervention to reduce substance use by adolescents involved in the criminal justice system: the RISKIT-CJS RCT. Coulton S, Nizalova O, Pellatt-Higgins T, Stevens A, Hendrie N, Marchand C, Vass R, Deluca P, Drummond C, Ferguson J, Waller G, Newbury-Birch D. Public Health Res (Southampt); 2023 Mar 11; 11(3):1-77. PubMed ID: 37254608 [Abstract] [Full Text] [Related]